Certified by Founder
Lodge
Relief Cardiovascular
start up
United States
- Costa Mesa, CA
- 09/01/2025
- Series A
- $12,000,000
Relief Cardiovascular, an inQB8 Medical Technologies portfolio company, is creating a novel smart implant to decongest heart failure patients.
The Relief System is the world’s first transcatheter implant to both monitor and modulate renal vein pressures, offering a novel solution for managing fluid in heart failure patients – particularly for the millions of heart failure patients with diuretic resistance.
- Industry Medical Equipment Manufacturing
- Website https://www.reliefcardio.com/
- LinkedIn https://www.linkedin.com/company/relief-cardiovascular/
Claros | $30,000,000 | (Mar 20, 2026)
Avtal | $24,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Raven.io | $20,000,000 | (Mar 19, 2026)
Manifold Security | $8,000,000 | (Mar 19, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
xmemory | $4,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
Multiply(US) | $9,500,000 | (Mar 19, 2026)
Respan (formerly Keywords AI) | $5,000,000 | (Mar 19, 2026)